India Ratings (Ind-Ra) predicts a recovery in API prices for FY27, driven by India's Minimum Import Price (MIP) and China’s withdrawal of export VAT rebates.
On Sept. 5, the FDA announced an import alert and green list for glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredient (API) manufacturers. The FDA included manufacturers on the green list ...
The FDA released a warning letter sent to Chinese API maker Qinhuangdao Zizhu Pharmaceutical in April that outlined data integrity problems at the company’s Hebei province facility following an ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...
Microsoft recently rolled out the ability to import Google Ad campaigns into Microsoft Advertising to run the same ads on Bing. This is an easy way for advertisers to broaden their online reach, ...
In a significant regulatory development aimed at controlling substandard imports, the Government of India has imposed price-based import restriction on sulfadiazine API, a key active pharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results